iA Global Asset Management’s AbbVie ABBV Stock Holding History

iA Global Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$170K	Sell	783 -1,067	-58%	-$237K	﹤0.01%	376
2025 Q4	$423K	Sell	1,850 -3,059	-62%	-$697K	0.01%	346
2025 Q3	$1.14M	Sell	4,909 -216	-4%	-$44K	0.02%	293
2025 Q2	$951K	Buy	5,125 +805	+19%	+$150K	0.01%	291
2025 Q1	$905K	Sell	4,320 -11,905	-73%	-$2.31M	0.02%	307
2024 Q4	$2.88M	Sell	16,225 -6,505	-29%	-$1.2M	0.05%	204
2024 Q3	$4.49M	Sell	22,730 -67,780	-75%	-$12.6M	0.08%	173
2024 Q2	$15.5M	Buy	90,510 +7,718	+9%	+$1.28M	0.3%	68
2024 Q1	$15.1M	Sell	82,792 -6,433	-7%	-$1.11M	0.31%	70
2023 Q4	$13.8M	Sell	89,225 -65,231	-42%	-$9.51M	0.32%	67
2023 Q3	$23M	Buy	154,456 +7,199	+5%	+$1.06M	0.61%	38
2023 Q2	$19.8M	Buy	+147,257	New	+$21.6M	0.53%	46

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

iA Global Asset Management's ABBV Position: Q1 2026 in Review

iA Global Asset Management reduced its AbbVie (ABBV) stake by 58% in Q1 2026, selling an estimated $237K and leaving 783 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #376.

iA Global Asset Management first reported a position in ABBV in Q2 2023 and has held it in 12 quarters since. The position peaked at $23M in Q3 2023. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

iA Global Asset Management held 783 shares of AbbVie worth $170K as of Q1 2026.
iA Global Asset Management sold 1,067 AbbVie shares in Q1 2026, an estimated $237K.
AbbVie made up ﹤0.01% of iA Global Asset Management's portfolio in Q1 2026, its #376 holding.
iA Global Asset Management first reported a position in AbbVie in Q2 2023 and has held it in 12 quarters since.
iA Global Asset Management's AbbVie position peaked at $23M in Q3 2023.
4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on iA Global Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.